Gynecologic Oncology Group
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Gynecologic Oncology Group sits in the top decile of US sponsors by registered trial count (#189 of 15,742 sponsors by registered trial count).
Gynecologic Oncology Group: 154 sponsored US clinical trials, 1 recruiting.
Gynecologic Oncology Group sponsors 154 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 115 completed. 27 of these trials are in Phase 3-4 (later-stage) and 107 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cervical Cancer, with 6 trials.
Top-decile sponsor footprint
Gynecologic Oncology Group ranks in the top decile of sponsors by registered trial count (#189 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
115 of 151 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (76.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
154 total, page 4 of 4
Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers
NCT00002538
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer
NCT00002478
Collecting Tumor Samples From Patients With Gynecological Tumors
NCT00897442
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer
NCT00002493
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 21 |
| Phase 2 | 86 |
| Phase 3 | 27 |
Therapeutic Areas
What is open in the Gynecologic Oncology Group pipeline
1 recruiting of 154 indexed (1% open); 115 completed (75%).
Phase mix: 27 late (III/IV) vs 107 early (I/II) (early-phase heavy).
Top condition: Cervical Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Gynecologic Oncology Group: open-pipeline peers nationwide
Peers matched on 154 registered trials and 1% open enrollment, not the therapeutic-area sidebar.
Gynecologic Oncology Group sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 154 trials (± recruiting share)
- Sanofi Pasteur, a Sanofi Company · 153 trials · 2% recruiting
- University of South Carolina · 157 trials · 19% recruiting
- Galderma R&D · 158 trials · 4% recruiting
- Pfizer's Upjohn has merged with Mylan to form Viatris · 158 trials · 0% recruiting
Sponsors near 1% open enrollment (± trial volume)
- Mylan Pharmaceuticals · 1% recruiting · 146 trials
- Johnson & Johnson Vision Care · 1% recruiting · 142 trials
- Shire · 0% recruiting · 245 trials
- Abbott Nutrition · 1% recruiting · 89 trials
Related
What to do with this Gynecologic Oncology Group page
154 registered trials is a research-attention snapshot, not an endorsement of Gynecologic Oncology Group or any single study.
- 1 of Gynecologic Oncology Group's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cervical Cancer is the condition Gynecologic Oncology Group studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cervical Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Gynecologic Oncology Group pipeline card: 154 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.